Gap junction blockers for migraine

A new category of migraine drugs referred to as gap junction blockers have been created that are meant to help millions find relieve from migraine attacks by preventing migraines from developing fully and displaying the crippling side effects.

The drugs are meant to help those who suffer from migraines regularly by changing the chemical signals in the brain that often trigger migraines into occurring. This far there have been a few trials in America that have shown the gap junction blockers have less side effects then the migraine prevention drugs that are now on the market.

University College London Professor Peter Goadsby stated at a London press conference this week that the drugs could help change the way that migraines are currently treated. He explained that the drugs seem to be tolerated well by most patients and if they prove to be as effective as scientists believe they could help change the way that migraines are medically treated.

He added that if the assumption is right about the signals in the brain that need to be altered, the following science could bring about later permanent cures to solving migraine problems for those that deal with chronic migraines on a regular basis.

According to Professor Goadsby, out of the nine million people that are diagnosed with migraines each year about two million are missing out on treatments that could prevent migraines and all of their accompanying symptoms before they even occur.

He estimates that about 38% of those who suffer from chronic migraines could see their problems erased with the gap junction blockers, although many more people that suffer from occasional acute migraines would also most likely want them. A lack of knowledge about preventative treatment for migraines is one of the largest reasons that people do not seek aid.